This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Ares Trading S.a.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations by Gabrielle Leclercq in Protein Glycosylation
Introduction
Gabrielle Leclercq is an accomplished inventor based in Lausanne, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the modulation of protein glycosylation profiles. Her innovative work has the potential to enhance the efficacy of recombinant proteins used in various applications.
Latest Patents
Gabrielle holds a patent titled "Methods for modulating protein galactosylation profiles of recombinant proteins using peracetyl galactose." This invention relates to methods and compositions for modulating the glycosylation profile, specifically the galactosylation profile, of recombinant proteins expressed by mammalian host cells. The process involves supplementing cell culture media with peracetyl galactose, which can significantly impact the quality and functionality of the produced proteins. She has 1 patent to her name.
Career Highlights
Gabrielle is currently employed at Ares Trading S.a., where she continues to push the boundaries of research and innovation in her field. Her work is characterized by a commitment to improving biotechnological processes and outcomes.
Collaborations
Gabrielle collaborates with notable colleagues, including Martin Jordan and Jonathan Souquet. Their combined expertise fosters a dynamic research environment that encourages innovative solutions in biotechnology.
Conclusion
Gabrielle Leclercq's contributions to the field of protein glycosylation represent a significant advancement in biotechnology. Her innovative methods have the potential to improve the production and functionality of recombinant proteins, showcasing her role as a leading inventor in this area.